ORG Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$175K Sell
641
-14
-2% -$3.8K 0.03% 353
2025
Q3
$177K Buy
655
+2
+0.3% +$544 0.03% 359
2025
Q2
$180K Buy
653
+130
+25% +$35.4K 0.04% 338
2025
Q1
$137K Sell
523
-812
-61% -$200K 0.03% 333
2024
Q4
$310K Buy
1,335
+925
+226% +$213K 0.04% 256
2024
Q3
$90.5K Buy
410
+2
+0.5% +$414 0.01% 401
2024
Q2
$79.8K Buy
408
+357
+700% +$73.8K 0.01% 674
2024
Q1
$10.8K Sell
51
-311
-86% -$65.3K 0.02% 279
2023
Q4
$76.3K Buy
362
+242
+202% +$51.6K 0.01% 447
2023
Q3
$24K Sell
120
-71
-37% -$14.1K 0.01% 659
2023
Q2
$35.6K Buy
+191
New +$35.3K 0.01% 741

Other funds holding CME

ORG Partners's CME Position: Q4 2025 in Review

ORG Partners reduced its CME Group (CME) stake by 2.1% in Q4 2025, selling an estimated $3.8K and leaving 641 shares worth $175K. The position accounts for 0.03% of the portfolio, ranked #353.

ORG Partners first reported a position in CME in Q2 2023 and has held it in 11 quarters since. The position peaked at $310K in Q4 2024. 1,731 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • ORG Partners held 641 shares of CME Group worth $175K as of Q4 2025.
  • ORG Partners sold 14 CME Group shares in Q4 2025, an estimated $3.8K.
  • CME Group made up 0.03% of ORG Partners's portfolio in Q4 2025, its #353 holding.
  • ORG Partners first reported a position in CME Group in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's CME Group position peaked at $310K in Q4 2024.
  • 1,731 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.